Non-valvular atrial fibrillation accounts for 13–26% of acute ischaemic strokes.1 Direct oral anticoagulants (DOACs) are highly effective in reducing the risk of ischaemic stroke with significantly ...

Tan rectangle encompass coagulation factors affected by vitamin K antagonism. Red arrowed boxes indicate interactions that inhibit anticoagulation. Green arrowed boxes indicate interactions that ...

Cadrenal Therapeutics highlights new research on the economic and medical burden associated with oral anticoagulation for LVAD patients.

Differences in thromboplastin responsiveness contributed to clinically important differences in oral anticoagulant dosing among countries 82 and were responsible for excessive and erratic ...

Background Oral anticoagulation (OAC) is key in stroke prevention in patients with atrial fibrillation (AF) but there is uncertainty regarding the optimal timing of OAC (re)initiation after stroke, as ...

With a headline reading “Freedom Trail Here, Too,” the Cambridge Chronicle of April 12, 1962, detailed the recommendations of the Cambridge Historic Districts Study Committee for a pathway that would ...

This Consensus Document is endorsed by the Anticoagulation Forum's Board of Directors: Jack E Ansell MD, Marc Crowther MD MSc, David Garcia MD, Alan Jacobson MD, Janet Delaney MSN ARNP-BC CACP ...

2–6 Reflecting uncertainty in the available body of evidence, Kidney Disease: Improving Global Outcomes (KDIGO) modified their 2011 consensus statement on cardiovascular disease to recommend against ...

Guangdong Laboratory for Lingnan Modern Agriculture, State Key Laboratory for Conservation and Utilization of Subtropical Agro-Bioresources, Guangdong Basic Research Center of Excellence for Precise ...

Both Vertex and Eli Lilly are entering the non-opioid pain management market, targeting the promising $20B+ opportunity. Vertex's Journavx, targeting NaV1.8, is FDA-approved and shows opioid-level ...

FANCM is crucial in genome maintenance, functioning in the Fanconi anemia (FA) pathway, alternative lengthening of telomeres (ALT), and replication fork protection. FANCM recognizes branched DNA ...